Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive medicine in urology.

Bernd J Schmitz-Dräger, Nuria Malats, Pierfrancesco Bassi

    World Journal of Urology
    |December 20, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Implementing predictive medicine and risk assessment for disease prevention can reduce incidence and costs. Focusing on high-risk individuals is key to lowering mortality and healthcare expenses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

    Cell reports. Medicine·2026
    Same author

    Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models.

    NPJ precision oncology·2026
    Same author

    Pancreatic cancer.

    Nature reviews. Disease primers·2026
    Same author

    Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.

    medRxiv : the preprint server for health sciences·2026
    Same author

    A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
    Same author

    Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.

    Nature communications·2026

    Area of Science:

    • Health Management
    • Preventive Medicine
    • Predictive Diagnostics

    Background:

    • Healthcare systems face financial constraints, necessitating innovative health management strategies.
    • Evidence from non-urological diseases indicates that preventive measures can decrease disease incidence and prove cost-effective.
    • Predictive medicine and risk assessment offer tools to identify individuals at elevated risk for developing specific diseases.

    Discussion:

    • Targeted prevention and screening programs focused on at-risk populations can yield significant benefits.
    • Integrating predictive analytics into healthcare can optimize resource allocation and improve patient outcomes.
    • The proactive identification of at-risk individuals is crucial for effective disease management and public health.

    Key Insights:

    Related Experiment Videos

    • Predictive medicine enables personalized risk assessment for disease development.
    • Proactive, risk-stratified prevention strategies are essential for cost containment in healthcare.
    • Early identification of at-risk individuals is paramount for reducing disease-related mortality.

    Outlook:

    • Future healthcare models should emphasize predictive diagnostics and personalized prevention.
    • Continued research into risk assessment tools will enhance the efficacy of preventive healthcare.
    • Widespread adoption of risk-based prevention could transform public health by reducing disease burden and healthcare costs.